urea has been researched along with Tachycardia in 60 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Landiolol resulted in significantly more patients with sepsis-related tachyarrhythmia achieving a heart rate of 60-94 bpm at 24 h and significantly reduced the incidence of new-onset arrhythmia." | 9.34 | Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. ( Kakihana, Y; Matsuda, N; Morimatsu, H; Morishima, E; Nagano, T; Nishida, O; Ogura, H; Okajima, M; Taniguchi, T; Yamada, Y, 2020) |
| " Landiolol, an ultrashort-acting β-blocker, was approved in 2013 for tachyarrhythmias in adult patients with heart failure." | 9.24 | Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial. ( Horigome, H; Iwamoto, M; Miura, M; Miyazaki, A; Nagano, T; Ohashi, N; Ono, H; Sagawa, K; Sakaguchi, H; Sumitomo, N; Suzuki, T; Takahashi, K; Takamuro, M; Takigiku, K; Tokunaga, C; Ueda, H; Ushinohama, H; Yoshimoto, J, 2017) |
| " The J-Land study was conducted to compare the efficacy and safety of landiolol, an ultra-short-acting β-blocker, with those of digoxin for swift control of tachycardia in AF/AFL in patients with LV dysfunction." | 9.17 | Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study). ( Aiba, T; Atarashi, H; Daimon, T; Fujino, K; Hori, M; Ikeda, T; Imai, Y; Inoue, H; Kinugawa, K; Kitakaze, M; Nagai, R; Nagano, T; Okamura, T; Sakamoto, A; Seino, Y; Shimizu, W; Yamashita, T, 2013) |
| "The results showed that bolus administration of landiolol was effective in the treatment of tachycardia during anesthesia in surgical patients." | 9.12 | Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study. ( Harasawa, R; Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T, 2006) |
| " In contrast, 2 mug/kg fentanyl frequently caused hypotension just before and 5 min after intubation." | 9.12 | The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension. ( Hidaka, K; Masuoka, M; Seki, S; Sugiura, S; Tsuchida, H, 2007) |
| "In the first study (n = 15), dose-dependent hemodynamic changes were studied when landiolol was administered immediately after induction of anesthesia." | 9.11 | Landiolol and esmolol prevent tachycardia without altering cerebral blood flow. ( Akihiro, T; Goto, F; Nishihara, F; Nishikawa, K; Obata, H; Saito, S; Yuki, N, 2005) |
| "The use of landiolol hydrochloride for HR control of non-arrhythmic tachycardia in critically ill infants is well tolerated." | 8.31 | Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension. ( Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M, 2023) |
| "The HEARTFUL study has demonstrated the efficacy of landiolol, by reducing heart rate or terminating tachycardia, in pediatric patients with supraventricular tachyarrhythmias." | 8.12 | Control of Heart Rate in Infant and Child Tachyarrhythmia With Reduced Cardiac Function Using Landiolol (HEARTFUL) - Results of a Prospective, Multicenter, Uncontrolled Clinical Study. ( Aoki, H; Fukunaga, H; Horigome, H; Miura, M; Miyazaki, A; Morishima, E; Ohashi, N; Oki, K; Ono, H; Sagawa, K; Sakaguchi, H; Sato, S; Sumitomo, N; Suzuki, T; Takei, K; Ueda, H, 2022) |
| "Clinical experience with landiolol use in patients with atrial fibrillation (AF) and a severely depressed left ventricular (LV) function is limited." | 7.96 | Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function. ( Akitsu, K; Fujino, T; Ikeda, T; Kinoshita, T; Koike, H; Shinohara, M; Suzuki, T; Wada, R; Yano, K, 2020) |
| "To validate the safety and efficacy of landiolol, a beta1-selective blocker, as a primary care option for postoperative tachycardia after transthoracic esophagectomy." | 7.80 | Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy. ( Ando, J; Fukuda, T; Kitamura, T; Mitsui, T; Mori, K; Nomura, S; Seto, Y; Shimizu, N; Wada, I; Yamada, K; Yamaguchi, D, 2014) |
| "Landiolol hydrochloride can be effectively and safely used in patients who develop tachyarrhythmia after esophagectomy." | 7.80 | Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy. ( Fujii, T; Fujiwara, M; Iwata, N; Kobayashi, D; Kodera, Y; Koike, M; Nakayama, G; Niwa, Y; Sugimoto, H; Tanaka, C, 2014) |
| "Landiolol was efficacious in treating tachyarrhythmia in pediatric cardiac surgery." | 7.79 | Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery. ( Abe, M; Hiramatsu, Y; Horigome, H; Kanemoto, S; Sakakibara, Y; Takahashi-Igari, M; Tokunaga, C, 2013) |
| "The purpose of this study was to evaluate effects of landiolol hydrochloride, which is an ultra-short-acting beta-1 selective blocker, for intraoperative tachycardia and to establish practical methods of administration of the drug." | 7.78 | [Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study]. ( Edanaga, M; Kirita, A; Koro, S; Kurihara, M; Mimura, M; Nakayama, Y; Ohsuda, M; Yamakage, M; Yamaya, K, 2012) |
| "We report successful anesthetic management of elective cesarean section in a 30-year-old patient with Basedow disease using landiolol hydrochloride, a short-acting beta-1 adrenergic blocker of which greatest advantages are its short duration of action, rapid clearance and high beta-1 selectivity." | 7.76 | [Landiolol hydrochloride is useful for anesthetic management of cesarean section in a patient with Basedow disease]. ( Namiki, A; Namiki, M; Tsukakubo, T; Tsumura, N, 2010) |
| "Postoperative treatment with carvedilol following landiolol has the effect of preventing tachycardia during AF after coronary artery bypass grafting." | 7.75 | Postoperative treatment of carvedilol following low dose landiolol has preventive effect for atrial fibrillation after coronary artery bypass grafting. ( Kawamura, T; Namai, A; Sakurai, M; Yoshioka, I, 2009) |
| "Prazosin was used as additional therapy in seven patients with severe chronic congestive cardiac failure." | 7.66 | Effect of prazosin on renal function in chronic congestive cardiac failure. ( Morgan, TO; Myers, JB; Walker, JN, 1981) |
| "Landiolol (Onoact(®)) is an intravenously administered, ultra short-acting β1-blocker with an elimination half-life of 3-4 min and ≈8-fold greater cardioselectivity than esmolol in vitro." | 6.49 | Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias. ( Plosker, GL, 2013) |
| "Landiolol was effective in terms of rate control and haemodynamics optimization, enabling de-escalation of catecholamine dosing in all patients." | 5.72 | Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series. ( Colombo, C; Ditali, V; Garatti, L; Morici, N; Oliva, F; Sacco, A; Villanova, L, 2022) |
| " No adverse effects were reported in any patient." | 5.62 | Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies. ( Ashida, A; Kishi, K; Konishi, H; Nemoto, S; Odanaka, Y; Ozaki, N, 2021) |
| "Landiolol was ineffective in the majority of AFl/AT patients." | 5.51 | Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction. ( Fujimoto, Y; Hayashi, H; Hayashi, M; Ito-Hagiwara, K; Iwasaki, YK; Maru, E; Oka, E; Shimizu, W; Yamamoto, T; Yodogawa, K, 2019) |
| "Landiolol was effective in treating critical tachyarrhythmia without hemodynamic deterioration." | 5.43 | Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study. ( Fujita, Y; Miyake, K; Miyazu, M; Sento, Y; Sobue, K; Tomita, M; Yoshimura, S; Yoshizawa, S, 2016) |
| "Aortic dissection is a lethal complication in pregnant women with Marfan syndrome." | 5.36 | Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section. ( Kawamoto, M; Saeki, N; Taguchi, S, 2010) |
| "Landiolol resulted in significantly more patients with sepsis-related tachyarrhythmia achieving a heart rate of 60-94 bpm at 24 h and significantly reduced the incidence of new-onset arrhythmia." | 5.34 | Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. ( Kakihana, Y; Matsuda, N; Morimatsu, H; Morishima, E; Nagano, T; Nishida, O; Ogura, H; Okajima, M; Taniguchi, T; Yamada, Y, 2020) |
| "Urea plays an important role in the urinary concentrating mechanism and expression of the urea transporters UT-A1, UT-A2, UT-A3, UT-A4, and UT-B is essential for tubular urea reabsorption." | 5.34 | Cytokine-mediated regulation of urea transporters during experimental endotoxemia. ( Bucher, M; Höcherl, K; Schmidt, C, 2007) |
| " Landiolol, an ultrashort-acting β-blocker, was approved in 2013 for tachyarrhythmias in adult patients with heart failure." | 5.24 | Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial. ( Horigome, H; Iwamoto, M; Miura, M; Miyazaki, A; Nagano, T; Ohashi, N; Ono, H; Sagawa, K; Sakaguchi, H; Sumitomo, N; Suzuki, T; Takahashi, K; Takamuro, M; Takigiku, K; Tokunaga, C; Ueda, H; Ushinohama, H; Yoshimoto, J, 2017) |
| " The J-Land study was conducted to compare the efficacy and safety of landiolol, an ultra-short-acting β-blocker, with those of digoxin for swift control of tachycardia in AF/AFL in patients with LV dysfunction." | 5.17 | Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study). ( Aiba, T; Atarashi, H; Daimon, T; Fujino, K; Hori, M; Ikeda, T; Imai, Y; Inoue, H; Kinugawa, K; Kitakaze, M; Nagai, R; Nagano, T; Okamura, T; Sakamoto, A; Seino, Y; Shimizu, W; Yamashita, T, 2013) |
| "The results showed that bolus administration of landiolol was effective in the treatment of tachycardia during anesthesia in surgical patients." | 5.12 | Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study. ( Harasawa, R; Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T, 2006) |
| " In contrast, 2 mug/kg fentanyl frequently caused hypotension just before and 5 min after intubation." | 5.12 | The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension. ( Hidaka, K; Masuoka, M; Seki, S; Sugiura, S; Tsuchida, H, 2007) |
| "In the first study (n = 15), dose-dependent hemodynamic changes were studied when landiolol was administered immediately after induction of anesthesia." | 5.11 | Landiolol and esmolol prevent tachycardia without altering cerebral blood flow. ( Akihiro, T; Goto, F; Nishihara, F; Nishikawa, K; Obata, H; Saito, S; Yuki, N, 2005) |
| "The use of landiolol hydrochloride for HR control of non-arrhythmic tachycardia in critically ill infants is well tolerated." | 4.31 | Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension. ( Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M, 2023) |
| "The HEARTFUL study has demonstrated the efficacy of landiolol, by reducing heart rate or terminating tachycardia, in pediatric patients with supraventricular tachyarrhythmias." | 4.12 | Control of Heart Rate in Infant and Child Tachyarrhythmia With Reduced Cardiac Function Using Landiolol (HEARTFUL) - Results of a Prospective, Multicenter, Uncontrolled Clinical Study. ( Aoki, H; Fukunaga, H; Horigome, H; Miura, M; Miyazaki, A; Morishima, E; Ohashi, N; Oki, K; Ono, H; Sagawa, K; Sakaguchi, H; Sato, S; Sumitomo, N; Suzuki, T; Takei, K; Ueda, H, 2022) |
| "Clinical experience with landiolol use in patients with atrial fibrillation (AF) and a severely depressed left ventricular (LV) function is limited." | 3.96 | Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function. ( Akitsu, K; Fujino, T; Ikeda, T; Kinoshita, T; Koike, H; Shinohara, M; Suzuki, T; Wada, R; Yano, K, 2020) |
| "To validate the safety and efficacy of landiolol, a beta1-selective blocker, as a primary care option for postoperative tachycardia after transthoracic esophagectomy." | 3.80 | Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy. ( Ando, J; Fukuda, T; Kitamura, T; Mitsui, T; Mori, K; Nomura, S; Seto, Y; Shimizu, N; Wada, I; Yamada, K; Yamaguchi, D, 2014) |
| "To conduct a cost-minimization analysis of landiolol for CT diagnosis of coronary heart diseases in patients with tachycardia in Japan." | 3.80 | Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan. ( Fujito, K; Fukuda, T; Hirano, M; Igarashi, A, 2014) |
| "Landiolol hydrochloride can be effectively and safely used in patients who develop tachyarrhythmia after esophagectomy." | 3.80 | Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy. ( Fujii, T; Fujiwara, M; Iwata, N; Kobayashi, D; Kodera, Y; Koike, M; Nakayama, G; Niwa, Y; Sugimoto, H; Tanaka, C, 2014) |
| "Landiolol was efficacious in treating tachyarrhythmia in pediatric cardiac surgery." | 3.79 | Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery. ( Abe, M; Hiramatsu, Y; Horigome, H; Kanemoto, S; Sakakibara, Y; Takahashi-Igari, M; Tokunaga, C, 2013) |
| "The purpose of this study was to evaluate effects of landiolol hydrochloride, which is an ultra-short-acting beta-1 selective blocker, for intraoperative tachycardia and to establish practical methods of administration of the drug." | 3.78 | [Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study]. ( Edanaga, M; Kirita, A; Koro, S; Kurihara, M; Mimura, M; Nakayama, Y; Ohsuda, M; Yamakage, M; Yamaya, K, 2012) |
| "We report successful anesthetic management of elective cesarean section in a 30-year-old patient with Basedow disease using landiolol hydrochloride, a short-acting beta-1 adrenergic blocker of which greatest advantages are its short duration of action, rapid clearance and high beta-1 selectivity." | 3.76 | [Landiolol hydrochloride is useful for anesthetic management of cesarean section in a patient with Basedow disease]. ( Namiki, A; Namiki, M; Tsukakubo, T; Tsumura, N, 2010) |
| "Postoperative treatment with carvedilol following landiolol has the effect of preventing tachycardia during AF after coronary artery bypass grafting." | 3.75 | Postoperative treatment of carvedilol following low dose landiolol has preventive effect for atrial fibrillation after coronary artery bypass grafting. ( Kawamura, T; Namai, A; Sakurai, M; Yoshioka, I, 2009) |
| " On the other hand, landiolol was effective for treating intraoperative hypertension and tachycardia." | 3.75 | [General anesthesia for cesarean section in a patient with moyamoya disease]. ( Asano, N; Ishiyama, T; Matsukawa, T; Sugihara, K, 2009) |
| " Tachycardia of 140 beats x min(-1) persisted, and landiolol was continuously administered at a rate of 5-10 mg x hr(-1) after a 2." | 3.75 | [Case of thyroid crisis with persistent tachycardia diagnosed postoperatively]. ( Iijima, T; Iwao, Y; Kasuya, Y; Tamada, N; Yorozu, T, 2009) |
| " Intravenous administration of an ultra short acting beta-blocker, landiolol hydrochloride, controlled heart rate and improved tachyarrhythmia without significant change of blood pressure." | 3.72 | [Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case]. ( Fujii, G; Kasamatsu, M; Matsuura, A; Miyahara, K; Shimomura, T; Suzuki, S; Yoshida, K, 2004) |
| "Landiolol controlled tachyarrhythmias associated with theophylline toxicity." | 3.70 | Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs. ( Fujii, Y; Hoshi, T; Inomata, S; Miyabe, M; Takahashi, S; Toyooka, H, 2000) |
| "Prazosin was used as additional therapy in seven patients with severe chronic congestive cardiac failure." | 3.66 | Effect of prazosin on renal function in chronic congestive cardiac failure. ( Morgan, TO; Myers, JB; Walker, JN, 1981) |
| "Landiolol (Onoact(®)) is an intravenously administered, ultra short-acting β1-blocker with an elimination half-life of 3-4 min and ≈8-fold greater cardioselectivity than esmolol in vitro." | 2.49 | Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias. ( Plosker, GL, 2013) |
| "Landiolol was effective in terms of rate control and haemodynamics optimization, enabling de-escalation of catecholamine dosing in all patients." | 1.72 | Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series. ( Colombo, C; Ditali, V; Garatti, L; Morici, N; Oliva, F; Sacco, A; Villanova, L, 2022) |
| " No adverse effects were reported in any patient." | 1.62 | Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies. ( Ashida, A; Kishi, K; Konishi, H; Nemoto, S; Odanaka, Y; Ozaki, N, 2021) |
| "Landiolol was ineffective in the majority of AFl/AT patients." | 1.51 | Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction. ( Fujimoto, Y; Hayashi, H; Hayashi, M; Ito-Hagiwara, K; Iwasaki, YK; Maru, E; Oka, E; Shimizu, W; Yamamoto, T; Yodogawa, K, 2019) |
| "Landiolol was effective in treating critical tachyarrhythmia without hemodynamic deterioration." | 1.43 | Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study. ( Fujita, Y; Miyake, K; Miyazu, M; Sento, Y; Sobue, K; Tomita, M; Yoshimura, S; Yoshizawa, S, 2016) |
| "Aortic dissection is a lethal complication in pregnant women with Marfan syndrome." | 1.36 | Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section. ( Kawamoto, M; Saeki, N; Taguchi, S, 2010) |
| "Urea plays an important role in the urinary concentrating mechanism and expression of the urea transporters UT-A1, UT-A2, UT-A3, UT-A4, and UT-B is essential for tubular urea reabsorption." | 1.34 | Cytokine-mediated regulation of urea transporters during experimental endotoxemia. ( Bucher, M; Höcherl, K; Schmidt, C, 2007) |
| "Treatment with enalapril (n = 7) during pacing reduced the decrease in aortic flow by 33% and prevented changes in plasma urea, potassium, and sodium." | 1.28 | Converting enzyme inhibition by enalapril in experimental heart failure. ( Bassenge, E; Holtz, J; Munzel, T; Sommer, O, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (10.00) | 18.7374 |
| 1990's | 4 (6.67) | 18.2507 |
| 2000's | 17 (28.33) | 29.6817 |
| 2010's | 25 (41.67) | 24.3611 |
| 2020's | 8 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ditali, V | 1 |
| Garatti, L | 1 |
| Morici, N | 1 |
| Villanova, L | 1 |
| Colombo, C | 1 |
| Oliva, F | 1 |
| Sacco, A | 1 |
| Sagawa, K | 2 |
| Suzuki, T | 3 |
| Takei, K | 1 |
| Miura, M | 2 |
| Ueda, H | 2 |
| Horigome, H | 3 |
| Ono, H | 2 |
| Ohashi, N | 2 |
| Sato, S | 1 |
| Fukunaga, H | 1 |
| Aoki, H | 1 |
| Miyazaki, A | 2 |
| Sakaguchi, H | 2 |
| Morishima, E | 2 |
| Oki, K | 1 |
| Sumitomo, N | 2 |
| Schroeder, L | 1 |
| Monno, P | 1 |
| Unger, M | 1 |
| Ackerl, J | 1 |
| Shatilova, O | 1 |
| Schmitt, J | 1 |
| Dresbach, T | 1 |
| Mueller, A | 1 |
| Kipfmueller, F | 1 |
| Dabrowski, W | 1 |
| Siwicka-Gieroba, D | 1 |
| Piasek, E | 1 |
| Schlegel, TT | 1 |
| Jaroszynski, A | 1 |
| Kakihana, Y | 1 |
| Nishida, O | 1 |
| Taniguchi, T | 1 |
| Okajima, M | 1 |
| Morimatsu, H | 1 |
| Ogura, H | 1 |
| Yamada, Y | 1 |
| Nagano, T | 3 |
| Matsuda, N | 1 |
| Morelli, A | 1 |
| Whitehouse, T | 1 |
| Rehberg, S | 1 |
| Shinohara, M | 1 |
| Wada, R | 1 |
| Yano, K | 1 |
| Akitsu, K | 1 |
| Koike, H | 1 |
| Kinoshita, T | 1 |
| Fujino, T | 1 |
| Ikeda, T | 2 |
| Ashida, A | 2 |
| Ozaki, N | 1 |
| Kishi, K | 1 |
| Odanaka, Y | 1 |
| Nemoto, S | 1 |
| Konishi, H | 1 |
| Syed, YY | 1 |
| Ogiwara, K | 1 |
| Yasumura, R | 1 |
| Kobayashi, Y | 1 |
| Oka, E | 2 |
| Iwasaki, YK | 2 |
| Maru, E | 1 |
| Fujimoto, Y | 1 |
| Ito-Hagiwara, K | 1 |
| Hayashi, H | 1 |
| Yamamoto, T | 1 |
| Yodogawa, K | 1 |
| Hayashi, M | 1 |
| Shimizu, W | 3 |
| Nitta, D | 1 |
| Imamura, T | 1 |
| Momomura, S | 1 |
| Nagai, R | 1 |
| Kinugawa, K | 1 |
| Inoue, H | 1 |
| Atarashi, H | 1 |
| Seino, Y | 1 |
| Yamashita, T | 1 |
| Aiba, T | 1 |
| Kitakaze, M | 1 |
| Sakamoto, A | 2 |
| Imai, Y | 1 |
| Daimon, T | 1 |
| Fujino, K | 1 |
| Okamura, T | 1 |
| Hori, M | 1 |
| Tokunaga, C | 2 |
| Hiramatsu, Y | 1 |
| Kanemoto, S | 1 |
| Takahashi-Igari, M | 1 |
| Abe, M | 2 |
| Sakakibara, Y | 1 |
| Mori, K | 1 |
| Yamada, K | 1 |
| Fukuda, T | 2 |
| Mitsui, T | 1 |
| Kitamura, T | 1 |
| Yamaguchi, D | 1 |
| Ando, J | 1 |
| Wada, I | 1 |
| Nomura, S | 1 |
| Shimizu, N | 1 |
| Seto, Y | 1 |
| Ojima, T | 1 |
| Iwahashi, M | 1 |
| Nakamori, M | 1 |
| Nakamura, M | 1 |
| Katsuda, M | 1 |
| Iida, T | 1 |
| Hayata, K | 1 |
| Yamaue, H | 1 |
| Plosker, GL | 1 |
| Igarashi, A | 1 |
| Fujito, K | 1 |
| Hirano, M | 1 |
| Niwa, Y | 1 |
| Koike, M | 1 |
| Iwata, N | 1 |
| Kobayashi, D | 1 |
| Tanaka, C | 1 |
| Fujii, T | 1 |
| Nakayama, G | 1 |
| Sugimoto, H | 1 |
| Fujiwara, M | 1 |
| Kodera, Y | 1 |
| Yamashita, Y | 1 |
| Iguchi, M | 1 |
| Nakatani, R | 1 |
| Usui, T | 1 |
| Takagi, D | 1 |
| Hamatani, Y | 1 |
| Unoki, T | 1 |
| Ishii, M | 1 |
| Ogawa, H | 1 |
| Masunaga, N | 1 |
| Akao, M | 1 |
| Miyake, K | 1 |
| Fujita, Y | 2 |
| Yoshizawa, S | 1 |
| Tomita, M | 1 |
| Miyazu, M | 1 |
| Sento, Y | 1 |
| Yoshimura, S | 1 |
| Sobue, K | 1 |
| Takigiku, K | 1 |
| Yoshimoto, J | 1 |
| Ushinohama, H | 1 |
| Takahashi, K | 1 |
| Iwamoto, M | 1 |
| Takamuro, M | 1 |
| Yano, T | 1 |
| Iwasaki, T | 1 |
| Naruo, H | 1 |
| Tsuneyoshi, I | 1 |
| Suzuki, Y | 1 |
| Morihara, A | 1 |
| Desaki, Y | 1 |
| Terao, K | 1 |
| Kido, T | 1 |
| Semba, K | 1 |
| Takasaki, Y | 1 |
| Shimizu, T | 1 |
| Matsumoto, A | 1 |
| Aoki, M | 1 |
| Asano, N | 1 |
| Ishiyama, T | 1 |
| Sugihara, K | 1 |
| Matsukawa, T | 1 |
| Ideguchi, M | 1 |
| Kajiwara, K | 1 |
| Yoshikawa, K | 1 |
| Kato, S | 1 |
| Ishihara, H | 1 |
| Fujii, M | 1 |
| Fujisawa, H | 1 |
| Suzuki, M | 1 |
| Yoshioka, I | 1 |
| Sakurai, M | 1 |
| Namai, A | 1 |
| Kawamura, T | 1 |
| Goto, K | 1 |
| Hagiwara, S | 1 |
| Hidaka, S | 1 |
| Yamamoto, S | 1 |
| Kusaka, J | 1 |
| Yasuda, N | 1 |
| Shingu, C | 1 |
| Noguchi, T | 1 |
| Tamada, N | 1 |
| Kasuya, Y | 1 |
| Yorozu, T | 1 |
| Iijima, T | 1 |
| Iwao, Y | 1 |
| Saeki, N | 1 |
| Taguchi, S | 1 |
| Kawamoto, M | 1 |
| Namiki, M | 1 |
| Tsumura, N | 1 |
| Tsukakubo, T | 1 |
| Namiki, A | 1 |
| Shahid, IZ | 1 |
| Rahman, AA | 1 |
| Pilowsky, PM | 1 |
| Suehiro, K | 1 |
| Okutani, R | 1 |
| Ito, S | 1 |
| Konishi, T | 1 |
| Imazuru, T | 1 |
| Matsuzaki, K | 1 |
| Jikuya, T | 1 |
| Ohsuda, M | 1 |
| Edanaga, M | 1 |
| Mimura, M | 1 |
| Nakayama, Y | 1 |
| Kirita, A | 1 |
| Koro, S | 1 |
| Yamaya, K | 1 |
| Kurihara, M | 1 |
| Yamakage, M | 1 |
| Konishi, R | 1 |
| Maeda, R | 1 |
| Endo, I | 1 |
| Inoue, N | 1 |
| Seo, N | 1 |
| GARRETT, J | 1 |
| MOREIRA, G | 1 |
| OSSWALD, MW | 1 |
| GUIMARAES, S | 1 |
| Nishina, K | 1 |
| Mikawa, K | 1 |
| Yonemoto, Y | 1 |
| Sugimoto, Y | 1 |
| Shimomura, T | 1 |
| Fujii, G | 1 |
| Suzuki, S | 1 |
| Miyahara, K | 1 |
| Matsuura, A | 1 |
| Yoshida, K | 1 |
| Kasamatsu, M | 1 |
| Yoshida, Y | 1 |
| Hongo, T | 1 |
| Ogawa, R | 1 |
| Saito, S | 1 |
| Nishihara, F | 1 |
| Akihiro, T | 1 |
| Nishikawa, K | 1 |
| Obata, H | 1 |
| Goto, F | 1 |
| Yuki, N | 1 |
| Chawla, R | 1 |
| Tempe, DK | 1 |
| Rathee, S | 1 |
| Sharma, S | 1 |
| Harasawa, R | 1 |
| Hayashi, Y | 1 |
| Iwasaki, M | 1 |
| Kamibayashi, T | 1 |
| Mashimo, T | 1 |
| Sugiura, S | 1 |
| Seki, S | 1 |
| Hidaka, K | 1 |
| Masuoka, M | 1 |
| Tsuchida, H | 1 |
| Schmidt, C | 1 |
| Höcherl, K | 1 |
| Bucher, M | 1 |
| Izumi, S | 1 |
| Kakinohana, M | 1 |
| Noguchi, N | 1 |
| Nakamura, S | 1 |
| Sugahara, K | 1 |
| Sanui, M | 1 |
| Matsuo, K | 1 |
| Sunagawa, H | 1 |
| Myers, JB | 1 |
| Morgan, TO | 1 |
| Walker, JN | 1 |
| Evans, AE | 1 |
| Boyle, DM | 1 |
| Barber, JM | 1 |
| McIlmoyle, EL | 1 |
| Walsh, MJ | 1 |
| Chaturvedi, NC | 1 |
| Mackenzie, G | 1 |
| Elwood, JH | 1 |
| Aranda-Michel, J | 1 |
| Morgan, SL | 1 |
| Yoshiya, I | 1 |
| Takahashi, S | 1 |
| Fujii, Y | 1 |
| Hoshi, T | 1 |
| Inomata, S | 1 |
| Miyabe, M | 1 |
| Toyooka, H | 1 |
| Iguchi, S | 1 |
| Iwamura, H | 1 |
| Nishizaki, M | 1 |
| Hayashi, A | 1 |
| Senokuchi, K | 1 |
| Kobayashi, K | 1 |
| Sakaki, K | 1 |
| Hachiya, K | 1 |
| Ichioka, Y | 1 |
| Kawamura, M | 1 |
| Holtz, J | 1 |
| Munzel, T | 1 |
| Sommer, O | 1 |
| Bassenge, E | 1 |
| Aynsley-Green, A | 1 |
| Pickering, D | 1 |
| Carruthers, SG | 1 |
| Kelly, JG | 1 |
| McDevitt, DG | 1 |
| Galloon, S | 1 |
| Rees, GA | 1 |
| Briscoe, CE | 1 |
| Davies, S | 1 |
| Kilpatrick, GS | 1 |
3 reviews available for urea and Tachycardia
| Article | Year |
|---|---|
Landiolol: A Review in Tachyarrhythmias.
Topics: Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Atrial Fibrillation; Dose-Respo | 2018 |
Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.
Topics: Animals; Humans; Intraoperative Complications; Morpholines; Postoperative Complications; Randomized | 2013 |
[Landiolol hydrochloride, a new sympathetic beta blocker].
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Clinical Trials as Topic; Humans; Morpholines; Tac | 1998 |
8 trials available for urea and Tachycardia
| Article | Year |
|---|---|
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Female; Humans; Male; Morpholines; Sepsis; Tachycardia | 2020 |
Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Flut | 2013 |
Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschoo | 2017 |
The effect of landiolol on cerebral blood flow in patients undergoing off-pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Cerebrovascular Circulation; Coronary Artery Byp | 2010 |
Landiolol attenuates cardiovascular response at induction of general anesthesia for cesarean delivery.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, General; Anesthesia, Obstetrical; Blood Pressure; Ce | 2012 |
Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anesthesia; Blood Pressure; Cerebrovascular Ci | 2005 |
Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anesthesia, General; Blood Pressure; Brain | 2006 |
The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arthroplasty, Replacement, Hip; Blood Pressure; Female; Fe | 2007 |
49 other studies available for urea and Tachycardia
| Article | Year |
|---|---|
Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series.
Topics: Heart Failure; Humans; Morpholines; Tachycardia; Urea | 2022 |
Control of Heart Rate in Infant and Child Tachyarrhythmia With Reduced Cardiac Function Using Landiolol (HEARTFUL) - Results of a Prospective, Multicenter, Uncontrolled Clinical Study.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Child; Heart Rate; Humans; Hypotension; Infant; Pr | 2022 |
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension.
Topics: Child; Critical Illness; Female; Heart Rate; Humans; Hypertension, Pulmonary; Infant; Infant, Newbor | 2023 |
Successful Combination of Landiolol and Levosimendan in Patients with Decompensated Heart Failure.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Drug Therapy, Combination; Female; Heart Fail | 2020 |
β-blockade in sepsis: regulation of persisting sepsis-related tachycardia.
Topics: Humans; Morpholines; Sepsis; Tachycardia; Urea | 2020 |
Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; B | 2020 |
Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies.
Topics: Atrial Fibrillation; Child; Humans; Infant; Morpholines; Retrospective Studies; Tachycardia; Urea | 2021 |
[Hyperthyroidism Diagnosed from Refractory Tachycardia and Hypotension during Surgery: A Case Report].
Topics: Blood Pressure; Female; Heart Rate; Humans; Hyperthyroidism; Hypotension; Injections, Intravenous; M | 2016 |
Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Male; Middle Aged; Morpho | 2019 |
What Determines the Response to Landiolol?
Topics: Atrial Fibrillation; Atrial Flutter; Humans; Morpholines; Tachycardia; Urea; Ventricular Dysfunction | 2019 |
What Determines the Response to Landiolol? - Reply.
Topics: Atrial Fibrillation; Atrial Flutter; Humans; Morpholines; Tachycardia; Urea; Ventricular Dysfunction | 2019 |
Acute rate control in atrial fibrillation with left ventricular dysfunction.
Topics: Adrenergic beta-1 Receptor Antagonists; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Female; Hea | 2013 |
Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
Topics: Adrenergic beta-Antagonists; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Heart Def | 2013 |
Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esopha | 2014 |
Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Colon; Esophageal | 2014 |
Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan.
Topics: Adrenergic beta-Antagonists; Coronary Angiography; Coronary Disease; Decision Trees; Health Expendit | 2014 |
Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium C | 2014 |
Thyroid Storm with Heart Failure Treated with a Short-acting Beta-adrenoreceptor Blocker, Landiolol Hydrochloride.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Electric Countershock; Female; Heart Failure | 2015 |
Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study.
Topics: Blood Pressure; Child; Child, Preschool; Cohort Studies; Female; Fontan Procedure; Heart Rate; Human | 2016 |
Use of landiolol for treatment of atrial fibrillation in a patient with terminal cancer.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Colonic Neoplasms; Female; Humans; Morpholines; T | 2010 |
Successful treatment with landiolol for the recurrence of significant ST-segment depression during early postoperative period.
Topics: Anti-Arrhythmia Agents; Endarterectomy, Carotid; Humans; Male; Middle Aged; Morpholines; Myocardial | 2008 |
[Perioperative and postoperative management of two patients with uncontrolled hyperthyroidism using short acting beta blocker, landiolol].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia; Antithyroid Agents; Fracture Fixation, Internal; Hum | 2008 |
[General anesthesia for cesarean section in a patient with moyamoya disease].
Topics: Adult; Anesthesia, General; Anesthesia, Obstetrical; Anti-Arrhythmia Agents; Cesarean Section; Emerg | 2009 |
Continuous hypertension and tachycardia after resection of a hemangioblastoma behind the dorsal medulla oblongata: relationship to sympathetic overactivity at the neurogenic vasomotor center.
Topics: Adrenergic beta-Antagonists; Autonomic Nervous System Diseases; Baroreflex; Brain Stem Neoplasms; Ca | 2010 |
Postoperative treatment of carvedilol following low dose landiolol has preventive effect for atrial fibrillation after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary Artery Bypass; Fe | 2009 |
[Case of thyroid crisis with persistent tachycardia diagnosed postoperatively].
Topics: Adult; Anti-Arrhythmia Agents; Emergencies; Fractures, Bone; Graves Disease; Humans; Intraoperative | 2009 |
Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section.
Topics: Adrenergic beta-Antagonists; Adult; Aortic Aneurysm; Aortic Dissection; Blood Pressure; Cesarean Sec | 2010 |
[Landiolol hydrochloride is useful for anesthetic management of cesarean section in a patient with Basedow disease].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spina | 2010 |
Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex.
Topics: Anesthesia, Spinal; Animals; Baroreflex; Benzoxazoles; Evoked Potentials, Somatosensory; Injections, | 2011 |
[Comparative study between landiolol and amiodarone for therapeutic efficacy after open heart surgery].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; | 2011 |
[Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, General; Female; Humans; Injections, Intraveno | 2012 |
[Successful control of rapid heart rate in a patient with atrial fibrillation by continuous intravenous administration of landiolol hydrochloride].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Male; Morpholines | 2003 |
ANTIARRHYTHMIC ACTIVITY OF N,N-DIISOPROPYL-N'-ISOAMYL-N'-DIETHYLAMINOETHYLUREA HYDROCHLORIDE (P-286).
Topics: Acetylcholine; Aconitum; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, P | 1964 |
The efficacy of bolus administration of landiolol for attenuating tachycardia in pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Aged, 80 and over; Anesthesia, General; Anti-Arrhythmi | 2004 |
[Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Humans; Infusions, Intravenous; Intraoperative | 2004 |
Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Hemodynamics; Humans; Intraoperative Complication | 2005 |
Landiolol and peri-induction tachycardia.
Topics: Adrenergic beta-Antagonists; Heart Rate; Humans; Intubation, Intratracheal; Morpholines; Tachycardia | 2006 |
Cytokine-mediated regulation of urea transporters during experimental endotoxemia.
Topics: Animals; Cytokines; Dexamethasone; Diuresis; Dose-Response Relationship, Drug; Endotoxemia; Gene Exp | 2007 |
[Anesthetic management for on-pump coronary arterial bypass graft in a patient with cardiac resynchronization therapy].
Topics: Aged; Anesthesia; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Artery Bypass; Humans | 2008 |
Low-dose landiolol for hypertension with tachycardia following neurosurgery.
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Female; Humans; Hypertension; M | 2008 |
Effect of prazosin on renal function in chronic congestive cardiac failure.
Topics: Adult; Aged; Body Weight; Creatinine; Gout; Heart Failure; Humans; Kidney; Male; Middle Aged; Prazos | 1981 |
Safe selection of coronary patients for early discharge.
Topics: Age Factors; Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Myocardial Infar | 1981 |
Overfeeding in a patient with Kwashiorkor syndrome.
Topics: Atrial Fibrillation; Energy Intake; Female; Humans; Hypercapnia; Kwashiorkor; Magnesium Deficiency; | 1996 |
Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Aminophylline; Analysis of Variance; Anesthetics, | 2000 |
Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Technique | 1992 |
Converting enzyme inhibition by enalapril in experimental heart failure.
Topics: Administration, Oral; Animals; Cardiac Output, Low; Cardiac Pacing, Artificial; Creatinine; Dogs; En | 1990 |
Use of central and peripheral temperature measurements in care of the critically ill child.
Topics: Blood Circulation; Blood Glucose; Blood Transfusion; Blood Volume; Body Temperature; Child, Preschoo | 1974 |
Plasma digoxin concentrations in patients on admission to hospital.
Topics: Aged; Creatinine; Digoxin; Female; Heart Block; Hospitalization; Humans; Male; Middle Aged; Nausea; | 1974 |
Prospective study of electrocardiographic changes associated with subarachnoid haemorrhage.
Topics: Blood; Blood Glucose; Bradycardia; Consciousness; Electrocardiography; Fever; Humans; Hydrogen-Ion C | 1972 |